ZG-096
重组人透明质酸酶 （北京诺博特生物科技有限公司）
Report date: 2025/08/12 15:42:53
Base Information
Drug NameZG-096
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Nuobot Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesBeijing Nuobot Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A